One Yale genetics expert argues that population-wide genomic screening would be worth it, even if only 1% of Americans were to learn they have genetic abnormalities that put them at high risk for deadly diseases.
Would Routine Genomic Testing For Cancer And Heart Risk Make Economic Sense?
